Chen Zhengtang, Zhuo Wenlei, Wang Yan, Ao Xujun, An Jianghong
Institute of Cancer, Xinqiao Hospital, Third Military Medical University, 400037 Chongqing, People's Republic of China.
Biotechnol Appl Biochem. 2008 Jun;50(Pt 2):89-96. doi: 10.1042/BA20070138.
Human lung carcinoma is a highly metastatic tumour that leads to a high death rate and in which lymphatic metastasis is an important early event. HYA (hyaluronan) is involved in the invasion of a variety of tumour cells. Layilin, a specific and novel HYA receptor, was detected in the human lung cell line A549 in our preliminary research, and was hypothesized to play an essential role in cell motility and tumour lymphatic metastasis. In the present study we found that, as expected, suppression of layilin expression by RNA interference significantly inhibited A549-cell invasion and migration in vitro and lymphatic metastasis in vivo and thereby resulted in the increased survival of tumour-bearing mice. These findings suggested that layilin might play crucial roles in lymphatic metastasis of lung carcinoma and that suppression of layilin expression might be a promising strategy for treatment of human lung carcinoma.
人类肺癌是一种具有高度转移性的肿瘤,导致高死亡率,其中淋巴转移是一个重要的早期事件。透明质酸(HYA)参与多种肿瘤细胞的侵袭。在我们的初步研究中,在人肺细胞系A549中检测到一种特异性新型HYA受体——层黏连蛋白,据推测它在细胞运动和肿瘤淋巴转移中起重要作用。在本研究中,我们发现,正如预期的那样,通过RNA干扰抑制层黏连蛋白表达可显著抑制A549细胞在体外的侵袭和迁移以及在体内的淋巴转移,从而提高荷瘤小鼠的生存率。这些发现表明,层黏连蛋白可能在肺癌的淋巴转移中起关键作用,抑制层黏连蛋白表达可能是治疗人类肺癌的一种有前景的策略。